The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
United States’ Food and Drug Administration landed on a major decision regarding the pain medication and the tendency for ...
The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...